Bioventix PLC
LSE:BVXP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bioventix PLC
LSE:BVXP
|
UK |
|
Innoviva Inc
NASDAQ:INVA
|
US |
Intrinsic Value
The intrinsic value of Bioventix PLC (BVXP) under the Base Case is 1 348.94 GBX per share.
Compared with the current market price of 2 064 GBX, the stock appears
Overvalued by 35% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Bioventix Does
Bioventix makes specialist antibodies that help medical test makers detect tiny amounts of substances in blood. Its main products are sheep-derived monoclonal antibodies used in diagnostic kits for hormones, heart markers, and other clinical tests. The company does not sell tests directly to hospitals; it sells the key biological ingredient that test manufacturers build into their own assays.
- Headquarters
- United Kingdom UK
- Employees
- 12
- IPO date
- Apr 29, 2014
Earnings Waterfall
Bioventix PLC
The intrinsic value for Bioventix PLC (BVXP) under the Base Case is 1 348.94 GBX.
Compared with the current market price of 2 064 GBX, the stock appears Overvalued by 35% .